Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Delivery Strategy to Enhance the Therapeutic Efficacy of Liver Fibrosis via Nanoparticle Drug Delivery Systems

Published:2024-07-31 Issue:32 Volume:18 Page:20861-20885
ISSN:1936-0851
Container-title:ACS Nano
language:en
Short-container-title:ACS Nano

Author:

Liu Jie¹,Liu Jinhu¹,Mu Weiwei¹,Ma Qingping¹,Zhai Xiangyu²,Jin Bin²³,Liu Yongjun¹,Zhang Na¹^ORCID

Affiliation:

1. Department of Pharmaceutics, Key Laboratory of Chemical Biology (Ministry of Education), NMPA Key Laboratory for Technology Research and Evaluation of Drug Products, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong 250012, China

2. Department of Hepatobiliary Surgery, The Second Hospital of Shandong University, Jinan, Shandong 250033, China

3. Organ Transplant Department, Qilu Hospital of Shandong University, Jinan, Shandong 250012, China

Funder

Shandong University

National Natural Science Foundation of China

Natural Science Foundation of Shandong Province

Science Fund for Distinguished Young Scholars of Shandong Province

Publisher

American Chemical Society (ACS)

Link

https://pubs.acs.org/doi/pdf/10.1021/acsnano.4c02380

Reference205 articles.

1. Burden of liver diseases in the world

2. Global burden of liver disease: 2023 update

3. Global liver disease burdens and research trends: Analysis from a Chinese perspective

4. Population screening for liver fibrosis: Toward early diagnosis and intervention for chronic liver diseases

5. Pathogenesis of Liver Fibrosis

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP